| scholarly article | Q13442814 |
| P356 | DOI | 10.1016/S0002-9440(10)63043-X |
| P8608 | Fatcat ID | release_vpaj2zn6bja2hfp64vyh5qunre |
| P932 | PMC publication ID | 1867043 |
| P698 | PubMed publication ID | 11696457 |
| P5875 | ResearchGate publication ID | 11658863 |
| P50 | author | Maureane Hoffman | Q42882680 |
| William Parker | Q96069939 | ||
| P2093 | author name string | W Parker | |
| S D Love | |||
| T L Ortel | |||
| J H Lawson | |||
| J D Day | |||
| R K Johnson | |||
| A P Lesher | |||
| J G Schoenecker | |||
| P2860 | cites work | Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 | Q25938983 |
| Interaction between human natural anti-alpha-galactosyl immunoglobulin G and bacteria of the human flora | Q28361310 | ||
| Antinuclear antibodies: diagnostic markers for autoimmune diseases and probes for cell biology | Q29618865 | ||
| Fibrin sealant in the United States: clinical use at the University of Virginia | Q30468097 | ||
| Acquired factor V inhibitors | Q33546321 | ||
| Clinical and laboratory manifestations of anti-factor V antibodies | Q33603024 | ||
| Natural adjuvants: endogenous activators of dendritic cells | Q33878894 | ||
| Systemic lupus erythematosus: a model for atherogenesis? | Q33922220 | ||
| Spontaneous murine lupus-like syndromes. Clinical and immunopathological manifestations in several strains | Q36342054 | ||
| Cardiac xenografts between primate species provide evidence for the importance of the alpha-galactosyl determinant in hyperacute rejection | Q38295357 | ||
| Topical thrombin and acquired coagulation factor inhibitors: clinical spectrum and laboratory diagnosis | Q40732016 | ||
| Natural anti-carbohydrate IgM in mice: dependence on age and strain | Q40734456 | ||
| Seroma formation following axillary dissection for breast cancer: risk factors and lack of influence of bovine thrombin | Q40914687 | ||
| Antigenic specificities of antiphospholipid autoantibodies: implications for clinical laboratory testing and diagnosis of the antiphospholipid syndrome | Q41197464 | ||
| Fibrin sealant: current and potential clinical applications | Q41348946 | ||
| A sprayable hemostat containing fibrillar collagen, bovine thrombin, and autologous plasma | Q41688775 | ||
| Development of anti-bovine thrombin antibodies following neurosurgical procedures | Q43569429 | ||
| Unexpected anti-alpha GalNAc antibodies in alpha-galactosyl transferase-deficient mice: complex relationship between genotype and the natural antibody repertoire. | Q43637198 | ||
| Conditioned stimulus as a determinant of the form of the Pavlovian conditioned response | Q44410050 | ||
| Clinical Significance of Antibodies to Bovine and Human Thrombin and Factor V After Surgical Use of Bovine Thrombin | Q45162760 | ||
| Man, apes, and Old World monkeys differ from other mammals in the expression of alpha-galactosyl epitopes on nucleated cells. | Q45972665 | ||
| Development of antithrombin antibodies following surgery in patients with prosthetic cardiac valves. | Q46795896 | ||
| Acquired inhibitors to factors V and X after exposure to topical thrombin: interference with monitoring of low molecular weight heparin and warfarin | Q47301020 | ||
| Prediction of myocardial infarction in dyslipidemic men by elevated levels of immunoglobulin classes A, E, and G, but not M. | Q47841056 | ||
| Oocyte Gal alpha 1,3Gal epitopes implicated in sperm adhesion to the zona pellucida glycoprotein ZP3 are not required for fertilization in the mouse | Q49039531 | ||
| Development of antibodies to thrombin and factor V with recurrent bleeding in a patient exposed to topical bovine thrombin | Q68606264 | ||
| Isolation and characterization of an acquired antithrombin antibody | Q68629745 | ||
| A role for immunogenic DNA in the pathogenesis of systemic lupus erythematosus | Q68931131 | ||
| Iatrogenic immunization with bovine thrombin: a mechanism for prolonged thrombin times after surgery | Q69770529 | ||
| Redo cardiac surgery: late bleeding complications from topical thrombin-induced factor V deficiency | Q70552266 | ||
| The fine specificity of monoclonal anti-DNA antibodies induced in normal mice by immunization with bacterial DNA | Q70621477 | ||
| Bovine thrombin-induced inhibitor of factor V and bleeding risk in postoperative neurosurgical patients. Report of three cases | Q70649241 | ||
| Immunization by bovine thrombin used with fibrin glue during cardiovascular operations. Development of thrombin and factor V inhibitors | Q70699014 | ||
| Immunologic assessment of patients treated with bovine fibrin as a hemostatic agent | Q71912222 | ||
| Fibrin glue in surgery: frequent development of inhibitors of bovine thrombin and human factor V | Q72311509 | ||
| Simultaneous occurrence of human antibodies directed against fibrinogen, thrombin, and factor V following exposure to bovine thrombin: effects on blood coagulation, protein C activation and platelet function | Q73351921 | ||
| Immunologic impact and clinical outcomes after surgical exposure to bovine thrombin | Q73352712 | ||
| Postoperative bleeding induced by topical bovine thrombin: report of two cases | Q73422864 | ||
| Modulation of an acquired coagulation factor V inhibitor with intravenous immune globulin | Q73454525 | ||
| Exposure to topical bovine thrombin during surgery elicits a response against the xenogeneic carbohydrate galactose alpha1-3galactose | Q73497727 | ||
| Severe bleeding due to factor V inhibitor after repeated operations using fibrin sealant containing bovine thrombin | Q73553905 | ||
| Antibodies to topical bovine thrombin correlate with access thrombosis | Q73740054 | ||
| Coagulopathy complicating intraoperative blood salvage in a patient who had idiopathic scoliosis. A case report | Q73741400 | ||
| Immunochemical analysis of polyspecific antibodies in patients exposed to bovine fibrin sealant | Q73991424 | ||
| Inhibitory anti-factor V antibodies bind to the factor V C2 domain and are associated with hemorrhagic manifestations | Q74576919 | ||
| Antiphospholipid antibodies in left-ventricular assist system recipients after exposure to topical bovine thrombin | Q74615915 | ||
| Risk and clinical significance of developing antibodies induced by topical thrombin preparations | Q77456890 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 1957-69 | |
| P577 | publication date | 2001-11-01 | |
| P1433 | published in | The American Journal of Pathology | Q4744259 |
| P1476 | title | Exposure of mice to topical bovine thrombin induces systemic autoimmunity | |
| P478 | volume | 159 |
| Q39868479 | Autologous platelet-rich fibrin matrix as cell therapy in the healing of chronic lower-extremity ulcers |
| Q42854911 | Bovine thrombin and systemic autoimmunity |
| Q37586947 | Clinical use of topical thrombin as a surgical hemostat |
| Q59289031 | Cytotoxicity analyses of Choukroun’s platelet-rich fibrin (PRF) on a wide range of human cells: The answer to a commercial controversy |
| Q81240317 | Estimating the pathogen safety of manufactured human plasma products: application to fibrin sealants and to thrombin |
| Q34468419 | Evaluation of the effect of calcium gluconate and bovine thrombin on the temporal release of transforming growth factor beta 1 and platelet-derived growth factor isoform BB from feline platelet concentrates. |
| Q42856092 | Immunological consequences of topical bovine thrombin |
| Q36201684 | In pursuit of xenoreactive antibodies: where has it gotten us? |
| Q79328814 | Laparoscopic oxidized cellulose (Surgicel) application for small uterine perforations |
| Q36174626 | Pathogenic antibodies to coagulation factors. Part II. Fibrinogen, prothrombin, thrombin, factor V, factor XI, factor XII, factor XIII, the protein C system and von Willebrand factor |
| Q91638895 | Protease Activated Receptor 4 as a Novel Modulator of Regulatory T Cell Function |
| Q35791420 | Protease-activated receptor-2 signaling triggers dendritic cell development |
| Q44247288 | Purification of salmon thrombin and its potential as an alternative to mammalian thrombins in fibrin sealants |
| Q79106589 | Relative purity of thrombin-based hemostatic agents used in surgery |
| Q91587845 | Sciatic Nerve Cut and Repair Using Fibrin Glue in Adult Mice |
| Q24622347 | Soft materials to treat central nervous system injuries: evaluation of the suitability of non-mammalian fibrin gels |
| Q35591873 | The blood coagulation system as a molecular machine |
| Q35376544 | The potential for salmon fibrin and thrombin to mitigate pain subsequent to cervical nerve root injury |
| Q37979181 | Thrombin use in surgery: an evidence-based review of its clinical use. |
Search more.